series-c-plus
Stage
2
Investors
About
ARMO Biosciences develops engineered cytokine and immune cell therapies to enhance the safety and efficacy of cancer immunotherapy treatments for solid tumors.
Explore ARMO Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.